GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » EV-to-Revenue

Eckert & Ziegler SE (XTER:EUZ) EV-to-Revenue : 3.29 (As of May. 07, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eckert & Ziegler SE's enterprise value is €809.3 Mil. Eckert & Ziegler SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €246.1 Mil. Therefore, Eckert & Ziegler SE's EV-to-Revenue for today is 3.29.

The historical rank and industry rank for Eckert & Ziegler SE's EV-to-Revenue or its related term are showing as below:

XTER:EUZ' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.58   Med: 1.45   Max: 15.27
Current: 3.29

During the past 13 years, the highest EV-to-Revenue of Eckert & Ziegler SE was 15.27. The lowest was 0.58. And the median was 1.45.

XTER:EUZ's EV-to-Revenue is ranked worse than
50.55% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.25 vs XTER:EUZ: 3.29

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-07), Eckert & Ziegler SE's stock price is €39.42. Eckert & Ziegler SE's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €11.81. Therefore, Eckert & Ziegler SE's PS Ratio for today is 3.34.


Eckert & Ziegler SE EV-to-Revenue Historical Data

The historical data trend for Eckert & Ziegler SE's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE EV-to-Revenue Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.17 4.86 10.48 4.20 3.46

Eckert & Ziegler SE Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.20 3.65 3.16 2.70 3.46

Competitive Comparison of Eckert & Ziegler SE's EV-to-Revenue

For the Medical Devices subindustry, Eckert & Ziegler SE's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's EV-to-Revenue falls into.



Eckert & Ziegler SE EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Eckert & Ziegler SE's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=809.281/246.093
=3.29

Eckert & Ziegler SE's current Enterprise Value is €809.3 Mil.
Eckert & Ziegler SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €246.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eckert & Ziegler SE  (XTER:EUZ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Eckert & Ziegler SE's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=39.42/11.806
=3.34

Eckert & Ziegler SE's share price for today is €39.42.
Eckert & Ziegler SE's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.81.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eckert & Ziegler SE EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE (XTER:EUZ) Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, D-13125
Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company. The company generates maximum revenue from Isotope products segment. Geographically, it derives a majority of revenue from Europe and also has a presence in North America, Asia-Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE (XTER:EUZ) Headlines

No Headlines